Post-Partum Haemorrhage
 

Post-Partum Haemorrhage

   

Post-Partum Haemorrhage

Home
Pregnancy Calendar
Pregnancy
Pregnancy and Childbirth
Pregnancy and Childbirth
Pregnancy and Childbirth
Pregnancy and Childbirth
Pregnancy and Childbirth
Pregnancy Date Calculator
Symptoms & Signs
Pregnancy - Antenatal Care
Pregnancy
Gestational Age
Gestational Age Intro
Morning Sickness
Smoking
Obesity
Diabetes in Pregnancy
Gestational Diabetes
Liver
Infections
Teen Pregnancy
Depression in Pregnancy
Headache
PET Definitions
Aetiology - Pre-Eclampsia and Eclampsia
Antepartum Haemorrhage
Intrautrine Growth Restriction - IUGR
Breech Presentation
Twins
Teenage Pregnancy.
Thromboprophylaxis in pregnancy and the puerperium
Premature Labour
Post-Maturity
Induction Of Labour
Planned Delivery
Water Birth
Operative Vaginal Delivery-Forceps Delivery
Vacuum Extraction Delivery
Shoulder Dystocia
Caesarean Section
Pregnancy and Childbirth
Obstetric Emergencies
Puerperium
Post-Partum Haemorrhage
Uterine Rupture
Childbirth
Perinatal Mortality
Breast Feeding

PUERPERIUM

Post-Partum Haemorrhage

Br J Obstet Gynaecol. 1996 Nov;103(11):1068-73.

A prospective cohort study of oxytocin plus ergometrine compared with oxytocin alone for prevention of postpartum haemorrhage.
Soriano D, Dulitzki M, Schiff E, Barkai G, Mashiach S, Seidman DS.

Department of Obstetrics and Gynecology, Sheba Medical Center, Tel-Hashomer, Israel.

Objectives:

To determine the safety and efficacy of intramuscular oxytocin plus ergometrine compared to intravenous oxytocin for prevention of postpartum haemorrhage, and the significance of administration at the end of the second stage of labour compared with that after the third stage.

Design:

A prospective cohort study.

Setting:

A university affiliated tertiary medical centre. PARTICIPANTS: Two thousand one hundred and eighty-nine women delivering singletons during 40 consecutive weeks.

Main Outcome Measures:

Postpartum haemorrhage (> 500 ml), prolonged third stage (> 30 min), retained placenta (> 60 min), elevated blood pressure (systolic > 150 mmHg, diastolic > 100 mmHg).

Results:

The rate of postpartum haemorrhage was not significantly different for oxytocin-ergometrine compared with oxytocin, when administered at the end of the second stage of labour (odds ratio 1.10, 95% confidence interval (CI) 0.75-1.61) or after the third stage (odds ratio 0.95, 95% CI 0.68-1.34). The patients receiving oxytocics at the end of the second stage of labour had significantly lower rates of postpartum haemorrhage, for both oxytocin-ergometrine (odds ratio 0.69, 95% CI 0.49-0.98) and oxytocin (odds ratio 0.60, 95% CI 0.41-0.87), compared with those treated after the third stage.

Conclusion:

Administration of oxytocin alone is as effective as the use of oxytocin plus ergometrine in the prevention of postpartum haemorrhage, but associated with a significantly lower rate of unpleasant maternal side effects. Oxytocics administered after delivery of the fetal head compared with after the placental expulsion are associated with a significantly lower rate of postpartum haemorrhage.

 

Back Home Up Next

 

pregnancy